Published in
Dove Press, Neuropsychiatric Disease and Treatment, (Volume 18), p. 2519-2527, 2022
DOI: 10.2147/ndt.s385631
Links
Tools
Serum NOX1 and Raftlin as New Potential Biomarkers of Interest in Schizophrenia: A Preliminary Study
Journal article published in 2022 by
Onur Hurşitoğlu 
,
Ergul Belge Kurutas ,
Rebecca Strawbridge ,
Omer Faruk Uygur,
Emrah Yildiz,
Thomas J. Reilly
,
Ergul Belge Kurutas ,
Rebecca Strawbridge ,
Omer Faruk Uygur,
Emrah Yildiz,
Thomas J. Reilly
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Data provided by 